Evidence map›Paper›PMID 28533365›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Prediction of disease activity in models of multiple sclerosis by molecular magnetic resonance imaging of P-selectin.

Antoine Philippe Fournier, Aurélien Quenault, Sara Martinez de Lizarrondo, Maxime Gauberti, Gilles Defer, Denis Vivien, Fabian Docagne, Richard Macrez

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. In vivo methods for imaging blood-brain barrier function and dysfunction.European journal of nuclear medicine and molecular imaging · 2023
    Review
  9. Review
  10. Article
  11. Contribution of Intravital Neuroimaging to Study Animal Models of Multiple Sclerosis.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  12. Review
  13. Persistent neuroinflammation and behavioural deficits after single mild traumatic brain injury.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A novel molecular magnetic resonance imaging agent targeting activated leukocyte cell adhesion molecule as demonstrated in mouse brain metastasis models.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  19. Article
  20. Dynamic capillary stalls in reperfused ischemic penumbra contribute to injury: A hyperacute role for neutrophils in persistent traffic jams.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Antoine Philippe FournierNormandie University, Unicaen, INSERM, Physiopathology and Imaging of Neurological Disorders, 14074 Caen, France.
Aurélien QuenaultNormandie University, Unicaen, INSERM, Physiopathology and Imaging of Neurological Disorders, 14074 Caen, France.
Sara Martinez de LizarrondoNormandie University, Unicaen, INSERM, Physiopathology and Imaging of Neurological Disorders, 14074 Caen, France.
Maxime GaubertiNormandie University, Unicaen, INSERM, Physiopathology and Imaging of Neurological Disorders, 14074 Caen, France.
Gilles DeferNormandie University, Unicaen, INSERM, Physiopathology and Imaging of Neurological Disorders, 14074 Caen, France.
Denis VivienNormandie University, Unicaen, INSERM, Physiopathology and Imaging of Neurological Disorders, 14074 Caen, France.
Fabian DocagneNormandie University, Unicaen, INSERM, Physiopathology and Imaging of Neurological Disorders, 14074 Caen, France; docagne@cyceron.fr.
Richard MacrezNormandie University, Unicaen, INSERM, Physiopathology and Imaging of Neurological Disorders, 14074 Caen, France.
Université de Caen Normandie · FRNormandie Université · FRInserm · FRPhysiopathologie et imagerie des troubles neurologiques

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New strategies for detecting disease activity in multiple sclerosis are being investigated to ameliorate diagnosis and follow-up of patients. Today, although magnetic resonance imaging (MRI) is widely used to diagnose and monitor multiple sclerosis, no imaging tools exist to predict the evolution of disease and the efficacy of therapeutic strategies. Here, we show that molecular MRI targeting the endothelial adhesion molecule P-selectin unmasks the pathological events that take place in the spinal cord of mice subjected to chronic or relapsing experimental autoimmune encephalomyelitis. This approach provides a quantitative spatiotemporal follow-up of disease course in relation to clinical manifestations. Moreover, it predicts relapse in asymptomatic mice and remission in symptomatic animals. Future molecular MRI targeting P-selectin may be used to improve diagnosis, follow-up of treatment, and management of relapse/remission cycles in multiple sclerosis patients by providing information currently inaccessible through conventional MRI techniques.

Indexed as

AnimalsBlood-Brain BarrierBrainContrast MediaDisease Models, AnimalDisease ProgressionEncephalomyelitis, Autoimmune, ExperimentalMagnetic Resonance ImagingMaleMiceMice, Inbred C57BLMultiple SclerosisP-SelectinRecurrenceSpinal CordContrast MediaP-Selectinblood–brain barriercontrast agentMPIOspinal cordUSPIO

Identifiers

PMID28533365
PMCPMC5468646
OpenAlexW2618644874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.